What are the dosing guidelines for Bactrim (trimethoprim‑sulfamethoxazole) in adults and children for typical infections and special situations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Bactrim (Trimethoprim-Sulfamethoxazole) Dosing Guidelines

For typical infections in adults and children, Bactrim dosing is based on the trimethoprim component at 8-10 mg/kg/day divided into two doses for most infections, with higher doses (15-20 mg/kg/day) reserved specifically for Pneumocystis jirovecii pneumonia (PCP) treatment. 1

Standard Dosing for Common Infections

Urinary Tract Infections and Shigellosis

Adults:

  • 1 double-strength (DS) tablet (160 mg TMP/800 mg SMX) every 12 hours for 10-14 days for UTIs 1
  • For shigellosis: same dose for 5 days 1
  • Alternative for pyelonephritis: 160 mg TMP/800 mg SMX twice daily for 14 days if organism is known to be susceptible 2

Children (≥2 months):

  • 40 mg/kg/day sulfamethoxazole and 8 mg/kg/day trimethoprim divided every 12 hours 1
  • Duration: 10 days for UTI, 5 days for shigellosis 1
  • Contraindicated in infants <2 months due to kernicterus risk 3, 1

Skin and Soft Tissue Infections (MRSA)

Adults:

  • 1-2 double-strength tablets twice daily 4

Children:

  • 8-12 mg/kg/day (based on TMP component) in 2 divided doses 4

Acute Exacerbations of Chronic Bronchitis

Adults only:

  • 1 DS tablet every 12 hours for 14 days 1

Special Situations

Pneumocystis jirovecii Pneumonia (PCP)

This requires substantially higher doses than other infections.

Treatment (Adults and Children >2 months):

  • 15-20 mg/kg/day TMP (75-100 mg/kg/day SMX) divided every 6 hours for 14-21 days 5, 1
  • Administer IV initially; switch to oral when acute pneumonitis resolves if no malabsorption 5
  • Recent evidence suggests lower doses (<15 mg/kg/day TMP) may have similar mortality with fewer adverse effects, though this remains investigational 6, 7

Prophylaxis:

Adults:

  • 1 DS tablet once daily 8, 9, 8, 10
  • Alternative: 1 single-strength tablet daily (better tolerated) 9

Children:

  • 150 mg/m² TMP with 750 mg/m² SMX per day in 2 divided doses, 3 consecutive days per week 11, 10
  • Maximum daily dose: 320 mg TMP/1600 mg SMX 11
  • Start at 4-6 weeks of age for HIV-exposed infants 9, 10

Pertussis (Alternative Agent)

When macrolides are contraindicated:

Adults:

  • 320 mg TMP/1600 mg SMX per day in 2 divided doses for 14 days 3

Children (>2 months):

  • 8 mg/kg/day TMP, 40 mg/kg/day SMX in 2 divided doses for 14 days 3

Traveler's Diarrhea

Adults:

  • 1 DS tablet every 12 hours for 5 days 1

Renal Impairment Adjustments

Critical dosing modifications are required:

  • CrCl >30 mL/min: Standard dosing 1
  • CrCl 15-30 mL/min: Reduce dose by 50% 1
  • CrCl <15 mL/min: Use not recommended 1

For severe renal failure requiring dosing: Increase dosing interval to 12 times the serum creatinine level in mg/dL (maximum 48 hours) 12

Key Safety Considerations

Absolute Contraindications

  • Infants <2 months (kernicterus risk) 3, 1
  • Pregnancy near term and nursing mothers (kernicterus risk in infant) 3
  • Known hypersensitivity to sulfonamides or trimethoprim 3

Common Adverse Effects Requiring Monitoring

  • Hematologic toxicity: Monitor CBC monthly, especially in children 11
  • Rash: Occurs in ~15% of HIV-infected children (lower than adults) 5
  • Stevens-Johnson syndrome: Discontinue permanently if occurs 5, 11
  • Renal toxicity: Maintain adequate hydration to prevent crystalluria 3
  • Hyperkalemia: Use caution with other potassium-sparing agents

Management of Adverse Reactions

  • Mild rash: Temporarily discontinue, restart when resolved 5, 11
  • Life-threatening reactions (anaphylaxis, Stevens-Johnson, hypotension): Permanently discontinue 11
  • Desensitization: Possible for patients with documented reactions who require therapy 11

Important Drug Interactions

Exercise caution with:

  • Methotrexate (increased toxicity) 3
  • Oral anticoagulants (enhanced effect) 3
  • Antidiabetic agents (hypoglycemia risk) 3
  • Thiazide diuretics (thrombocytopenia risk) 3
  • Anticonvulsants (altered levels) 3

Clinical Pearls

The IV formulation requires large dilution volumes that may cause fluid overload; monitor carefully 12. Peak TMP levels of 5-10 mcg/mL are therapeutic for PCP 12. Oral bioavailability is excellent (60.5% for SMX, 82% for TMP in one study), making oral therapy appropriate once acute illness resolves 13.

For PCP prophylaxis, TMP-SMX provides superior coverage compared to alternatives (pentamidine, dapsone, atovaquone) and offers cross-protection against toxoplasmosis and bacterial infections 9, 14. The three-times-weekly dosing regimen for prophylaxis minimizes toxicity while maintaining efficacy 11.

References

Related Questions

What dose of liquid Bactrim (trimethoprim‑sulfamethoxazole 200 mg/40 mg per 5 mL) should be given to a child weighing 21.6 kg?
What is the appropriate dose of 200 mg/40 mg Bactrim (trimethoprim‑sulfamethoxazole) for a child weighing 21.6 kg?
What is the appropriate Bactrim (sulfamethoxazole/trimethoprim) dosing for a 12-year-old patient weighing 106 lb (≈48 kg) with a MRSA skin infection?
What is the appropriate trimethoprim‑sulfamethoxazole (Bactrim) dosing for an 81‑year‑old patient with a breast abscess, and how should renal function affect the dose?
What is the appropriate pediatric prophylactic dose of trimethoprim‑sulfamethoxazole for immunocompromised children, including dosing for weight categories and infants under two months?
What glucose laboratory thresholds are used to diagnose diabetes?
After a two‑day course of bisacodyl 25 mg, I have mild abdominal bloating and passing flatus but no stool despite applying pressure; what should I do?
What is the correct term for a single bacterium?
Is cefdinir an appropriate oral option for treating uncomplicated diverticulitis, and what is the recommended dosing for an immunocompetent adult?
How should epigastric pain be managed in a patient taking tirzepatide who may have pancreatitis or severe gastritis?
Are any investigations required for lateral epicondylitis (tennis elbow)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.